Extended Sales: Save 30% on all our market research reports. 

days
hours
mins
sec
Sale!

United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 – 2032)

(10 customer reviews)

Original price was: $2,499.Current price is: $1,750. SALE 30%


   Download Free Sample


Content Info :190 pages

Published Date: March, 2024

Publisher: DPI Research

Region: United States

Historical Year: 2018 – 2022

Base Year: 2023

Forecast Years: 2024-2032

Why Choose DPI Research

  • Right People
  • Right Methodology
  • Right Support
  • Right Price
Guaranteed Safe Checkout

Description

The U.S. Self-Monitoring Blood Glucose Devices market size was accounted for USD 4,045 million in 2023 and it is expected to reach around USD 7,138 million by 2032 poised to grow at a noteworthy CAGR of 6.5% during the forecast period from 2024 to 2032.

Market  Trends:

Increased Diabetes Prevalence: The global rise in diabetes, fueled by factors such as an aging population, sedentary lifestyles and unhealthy diets, is a key driver of demand for SMBG devices.

Technological Advancements: Continuous glucose monitoring (CGM) systems are becoming increasingly popular compared to traditional blood glucose meters as they provide real-time insight into glucose levels without the need to take blood samples from the finger. Smart, connected devices that can be synchronized with mobile apps for better data management and analysis are also on the rise.

Patient Empowerment and Home Care: There is an increasing trend towards patients taking responsibility for their own health and trying to manage it from the comfort of their own home. This has been accelerated by the COVID-19 pandemic, which underlined the importance of remote monitoring and telemedicine.

Insurance and Reimbursement Policies: In many regions, favourable insurance and reimbursement policies for SMBG devices and supplies have supported market growth. However, the extent of coverage varies significantly across different countries and insurance plans.

Future Outlook:

The future of the SMBG market appears promising, with several key trends expected to shape its evolution:

 Integration with Digital Health Platforms: Increased integration with digital health platforms and medical recording systems for comprehensive health management.

Wearable Technology: The development of a non-invasive, wearable technology for continuous glucose monitoring is a potential game changer, even if there are still significant scientific and regulatory hurdles.

Personalized Diabetes Management: Advances in data analytics and artificial intelligence (AI) are expected to enable personalized, predictive insights into diabetes management.

Given the fast pace of technological innovation and the changing regulatory environment, the market for SMBG devices is likely to continue to evolve rapidly. Manufacturers that focus on improving accuracy, affordability and ease of use while navigating the complex regulatory environment will thrive in this growing market.

This Latest and Comprehensive the United States Self-Monitoring Blood Glucose Devices Market Research Report 2024 provides:

  • Comprehensive research methodology of the United States self-monitoring blood glucose devices market
  • Detailed and comprehensive market overview with important analyst insights
  • Insights into the market determinants stimulating the United States self-monitoring blood glucose devices market
  • Analysis of the historical growth of the market size of the United States self-monitoring blood glucose devices market from 2018 to 2023
  • The United States self-monitoring blood glucose devices market size estimation and forecast from 2024 to 2032 and growth rate up to 2032
  • An Insightful Study of the United States Diabetes Population and Forecast to 2032
  • Evaluate a Complete Overview of the United States Insulin Users and Forecast to 2032
  • The Market Size of the United States Blood Glucose Meter Market with Eight Years Forecast
  • The Market Size of the United States Blood Glucose Test Strips Market with Eight Years Forecast
  • The Market Size of the United States Blood Sugar Lancets Market with Eight Years Forecast
  • Get Facts and Insights of the United States Blood Glucose Meter Users Volume and Forecast to 2032
  • Get Facts and Insights of the United States Blood Glucose Test Strips Users Volume and Forecast to 2032
  • Get Facts and Insights of the United States Blood Glucose Lancets Users Volume and Forecast to 2032
  • Scrutinize the Key Growth Drivers and Challenges of the United States Self-Monitoring Blood Glucose Devices Market
  • Provides Key Trends with Respect to Collaboration Deals, Mergers & Acquisitions, Distribution Agreement, Exclusive Agreement, Partnership Deals, and Licensing Agreement
  • Detailed Insights into the Regulatory Framework of the United States Self-Monitoring Blood Glucose Devices Market
  • Features Reimbursement Patterns of the United States Self-Monitoring Blood Glucose Devices Market
  • A Comprehensive List of Key Market Players Along with the Analysis of their Current Blood Glucose Meter Portfolios, Business Overview, and Current Development
  • Each of the Major Players has been Profiled Based on Parameters such as Business Overview, Key Marketed Products, and Recent Developments

The Key Companies Dominating this Market for their Products, Services, and Continuous Product Developments are:

  • Roche
  • LifeScan, Inc
  • Arkray, Inc
  • ForaCare, Inc
  • Fifty50 Medical
  • iHealth Labs
  • Oak Tree Health
  • Livongo Health
  • Dario Health
  • One Drop
  • Sanofi
  • BioTel Care
  • Walgreens
  • i-SENS, Inc
  • Medtronic
  • S. Diagnostics
  • Omnis Health
  • Nova Diabetes Care
  • Trividia Health, Inc
  • Simple Diagnostics
  • Smart Meter LLC
  • Ascensia Diabetes Care
  • Abbott Diabetes Care
  • Genesis Health Technologies
  • Prodigy Diabetes Care, LLC
  • Omron Healthcare
  • Ypsomed Holding AG
  • Osang Healthcare Co., Ltd
  • Braun Holding GmbH & Co. KG.
  • Entra Health (Acquired by CRF Health)
  • Waveform Diabetes (Formerly AgaMatrix Holdings, LLC)

Key Questions Addressed by the Report:

  • How many people in the United States have diabetes?
  • How many people in the United States use insulin?
  • How has the United States self-monitoring blood glucose devices market performed so far?
  • How is the United States self-monitoring blood glucose devices market anticipated to evolve during the forecast period 2024 – 2032?
  • How is each segment of the United States self-monitoring blood glucose devices market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2032?
  • What are the main drivers and restraints in the United States self-monitoring blood glucose devices market?
  • What are the major deals happenings in the United States self-monitoring blood glucose devices market?
  • What are the various SMBG devices available in the United States?
  • What is the reimbursement scenario of the products offered in the United States self-monitoring blood glucose devices market?
  • What is the regulatory system of the self-monitoring blood glucose devices market in the United States?
  • Who are the top market players and what are their happenings, products, current developments, and scenarios?

Table of Contents

1. Introduction
2. Research Methodology
3. Executive Summary
4. United States Diabetes Population and Forecast, 2018 – 2032
5. United States Insulin Users Volume and Forecast, 2018 – 2032
6. United States Self-Monitoring Blood Glucose (SMBG) Market Size and Forecast, 2018 – 2032
7. United States Self-Monitoring Blood Glucose (SMBG) Market Share: By Segment
8. United States Self-Monitoring Blood Glucose (SMBG) Market: Segment Analysis and Forecasts,2018 – 2032
8.1 Blood Glucose Meter Users Volume Assessment
8.2 Blood Glucose Meter Market
8.3 Blood Glucose Test Strip Users Volume Assessment
8.4 Blood Glucose Test Strip Market
8.5 Blood Glucose Lancet Users Volume Assessment
8.6 Blood Glucose Lancet Market
9. Key Market Drivers and Inhibitors of the United States Self-Monitoring Blood Glucose Devices Market
9.1 Market Drivers
9.2 Market Challenges
10. Reimbursement Environment of the United States Self-Monitoring Blood Glucose Devices Market
11. Regulatory Framework of the United States Self-Monitoring Blood Glucose Devices Market
12. Recent Industry Developments and Deals in the Self-Monitoring Blood Glucose Devices Market
12.1 Collaboration Deals
12.2 Licensing Agreement
12.3 Partnership Deals
12.4 Distribution Agreement
12.5 Exclusive Agreement
12.6 Mergers & Acquisitions
13. Key Companies Profiles (Business Overview, Key Marketed Products, and Recent Development)
13.1 Roche
13.2 LifeScan, Inc
13.3 Abbott Diabetes Care
13.4 Arkray, Inc
13.5 Ascensia Diabetes Care
13.6 Waveform Diabetes (Formerly AgaMatrix Holdings, LLC)
13.7 ForaCare, Inc
13.8 Entra Health (Acquired by CRF Health)
13.9 Fifty50 Medical
13.10 Genesis Health Technologies
13.11 iHealth Labs
13.12 Oak Tree Health
13.13 Livongo Health
13.14 Nova Diabetes Care
13.15 Sanofi
13.16 BioTel Care
13.17 Walgreens
13.18 U.S. Diagnostics
13.19 Prodigy Diabetes Care, LLC
13.20 Omnis Health
13.21 Trividia Health, Inc
13.22 Simple Diagnostics
13.23 Dario Health
13.24 One Drop
13.25 Smart Meter LLC
13.26 B. Braun Holding GmbH & Co. KG.
13.27 i-SENS, Inc
13.28 Omron Healthcare
13.29 Medtronic
13.30 Ypsomed Holding AG
13.31 Osang Healthcare Co., Ltd
14. Appendix
14.1 About DPI Research
14.2 Glossary of Terms

List of Figures:

Figure 4-1: United States Diabetes Population (Thousand), 2018 – 2023
Figure 4-2: United States Diabetes Population Forecast (Thousand), 2024 – 2032
Figure 5-1: United States Insulin Users (Thousand),2018 – 2023
Figure 5-2: United States Insulin Users Forecast (Thousand),2024 – 2032
Figure 6-1: United States Self-Monitoring Blood Glucose (SMBG) Market (Million US$),2018 – 2023
Figure 6-2: United States Self-Monitoring Blood Glucose (SMBG) Market Forecast (Million US$),2024 – 2032
Figure 8-1: United States Blood Glucose Meter Users (Thousand), 2018 – 2023
Figure 8-2: United States Blood Glucose Meter Users Forecast (Thousand), 2024 – 2032
Figure 8-3: United States Blood Glucose Meter Market (Million US$), 2018 – 2023
Figure 8-4: United States Blood Glucose Meter Market Forecast (Million US$), 2024 – 2032
Figure 8-5: United States Blood Glucose Test Strip Users Volume Assessment (Thousand), 2018 – 2023
Figure 8-6: United States Blood Glucose Test Strip Users Volume Assessment Forecast (Thousand), 2024 – 2032
Figure 8-7: United States Blood Glucose Test Strip Market (Million US$), 2018 – 2023
Figure 8-8: United States Blood Glucose Test Strip Market Forecast (Million US$), 2024 – 2032
Figure 8-9: United States Blood Glucose Lancet Users Volume Assessment (Thousand), 2018 – 2023
Figure 8-10: United States Blood Glucose Lancet Users Volume Assessment Forecast (Thousand), 2024 – 2032
Figure 8-11: United States Blood Glucose Lancet Market (Million US$), 2018 – 2023
Figure 8-12: United States Blood Glucose Lancet Market Forecast (Million US$), 2024 – 2032

List of Tables:

Table 7-1: United States Self-Monitoring Blood Glucose (SMBG) Market Share: By Segment (Percent),2018 – 2023
Table 7-2: United States Self-Monitoring Blood Glucose (SMBG) Market Share Forecast: By Segment (Percent),2024 – 2032
Table 9-1: Worldwide Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 12-1: Collaboration Deals in Self-Monitoring Blood Glucose Market
Table 12-2: Licensing Agreement in Self-Monitoring Blood Glucose Market
Table 12-3: Partnership Deals in Self-Monitoring Blood Glucose Market
Table 12-4: Distribution Agreement in Self-Monitoring Blood Glucose Market
Table 12-5: Exclusive Agreement in Self-Monitoring Blood Glucose Market
Table 12-6: Merger & Acquisition in Self-Monitoring Blood Glucose Market
Table 13-1: Roche Blood Glucose Meter Marketed Products
Table 13-2: LifeScan Blood Glucose Meter Marketed Products
Table 13-3: Abbott Diabetes Care Blood Glucose Meter Marketed Products
Table 13-4: Arkray Blood Glucose Meter Marketed Products
Table 13-5: Ascensia Diabetes Care Blood Glucose Meter Marketed Products
Table 13-6: AgaMatrix: Blood Glucose Meter Marketed Products
Table 13-7: Fora Care: Blood Glucose Meter Marketed Products
Table 13-8: Entra Health Blood Glucose Meter Marketed Products
Table 13-9: Fifty50 Medical Blood Glucose Meter Marketed Products
Table 13-10: Genesis Health Technologies Blood Glucose Meter Marketed Products
Table 13-11: iHealth Labs Blood Glucose Meter Marketed Products
Table 13-12: Oak Tree Health Blood Glucose Meter Marketed Products
Table 13-13: Livongo Health Blood Glucose Meter Marketed Products
Table 13-14: Nova Diabetes Care Blood Glucose Meter Marketed Products
Table 13-15: Sanofi Diabetes Blood Glucose Meter Marketed Products
Table 13-16: Telcare Blood Glucose Meter Marketed Products
Table 13-17: Walgreens Blood Glucose Meter Marketed Products
Table 13-18: U.S. Diagnostics Blood Glucose Meter Marketed Products
Table 13-19: Prodigy Diabetes Care Blood Glucose Meter Marketed Products
Table 13-20: Omnis Health Blood Glucose Meter Marketed Products
Table 13-21: Trividia Health Blood Glucose Meter Marketed Products
Table 13-22: Simple Diagnostics Blood Glucose Meter Marketed Products
Table 13-23: Dario Health Blood Glucose Meter Marketed Products
Table 13-24: One Drop Blood Glucose Meter Marketed Products
Table 13-25: Smart Meter, LLC Blood Glucose Meter Marketed Products

Companies Mentioned

The Key Companies Dominating this Market for their Products, Services, and Continuous Product Developments are:

  • Roche
  • LifeScan, Inc
  • Arkray, Inc
  • ForaCare, Inc
  • Fifty50 Medical
  • iHealth Labs
  • Oak Tree Health
  • Livongo Health
  • Dario Health
  • One Drop
  • Sanofi
  • BioTel Care
  • Walgreens
  • i-SENS, Inc
  • Medtronic
  • S. Diagnostics
  • Omnis Health
  • Nova Diabetes Care
  • Trividia Health, Inc
  • Simple Diagnostics
  • Smart Meter LLC
  • Ascensia Diabetes Care
  • Abbott Diabetes Care
  • Genesis Health Technologies
  • Prodigy Diabetes Care, LLC
  • Omron Healthcare
  • Ypsomed Holding AG
  • Osang Healthcare Co., Ltd
  • Braun Holding GmbH & Co. KG.
  • Entra Health (Acquired by CRF Health)
  • Waveform Diabetes (Formerly AgaMatrix Holdings, LLC)

10 reviews for United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 – 2032)

  1. Richard (verified owner)

    Very fast delivery.

  2. Angel (verified owner)

    Very well worth the money.

  3. Henry (verified owner)

    Very fast delivery.

  4. Kayden (verified owner)

    Good quality.

  5. Anthony (verified owner)

    Very fast delivery.

  6. Samuel (verified owner)

    Very fast delivery.

  7. John (verified owner)

    Good quality.

  8. Matthew (verified owner)

    The product is firmly packed.

  9. Zane (verified owner)

    Good service.

  10. Ryder (verified owner)

    Good service.

Add a review

Your email address will not be published. Required fields are marked *

Good quality.Good service.The product is firmly packed.Very fast delivery.Very well worth the money.